News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,268 Results
Type
Article (14127)
Company Profile (109)
Press Release (257028)
Multimedia
Podcasts (61)
Webinars (13)
Section
Business (88292)
Career Advice (466)
Deals (15382)
Drug Delivery (69)
Drug Development (36795)
Employer Resources (50)
FDA (6356)
Job Trends (6225)
News (150762)
Policy (14123)
Tag
Academia (441)
Accelerated approval (6)
Adcomms (7)
Allergies (57)
Alliances (23333)
ALS (49)
Alzheimer's disease (451)
Antibody-drug conjugate (ADC) (75)
Approvals (6465)
Artificial intelligence (165)
Autoimmune disease (21)
Automation (6)
Bankruptcy (150)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (91)
Biotechnology (40)
Bladder cancer (32)
Brain cancer (25)
Breast cancer (130)
Cancer (1061)
Cardiovascular disease (123)
Career advice (416)
Career pathing (13)
CAR-T (36)
CDC (6)
Cell therapy (125)
Cervical cancer (8)
Clinical research (31691)
Collaboration (553)
Compensation (265)
Complete response letters (29)
COVID-19 (775)
CRISPR (36)
C-suite (308)
Cystic fibrosis (51)
Data (1326)
Denatured (17)
Depression (28)
Diabetes (114)
Diagnostics (1370)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (89)
Drug pricing (102)
Drug shortages (12)
Duchenne muscular dystrophy (71)
Earnings (33070)
Editorial (16)
Employer branding (4)
Employer resources (45)
Events (38463)
Executive appointments (510)
FDA (7226)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (343)
Gene editing (57)
Generative AI (12)
Gene therapy (142)
GLP-1 (412)
Government (1378)
Grass and pollen (4)
Guidances (143)
Healthcare (3575)
HIV (7)
Huntington's disease (6)
IgA nephropathy (28)
Immunology and inflammation (58)
Immuno-oncology (4)
Indications (29)
Infectious disease (828)
Inflammatory bowel disease (66)
Inflation Reduction Act (7)
Influenza (19)
Intellectual property (88)
Interviews (60)
IPO (5912)
IRA (33)
Job creations (2055)
Job search strategy (374)
Kidney cancer (9)
Labor market (26)
Layoffs (204)
Leadership (8)
Legal (3445)
Liver cancer (21)
Longevity (6)
Lung cancer (158)
Lymphoma (89)
Machine learning (8)
Management (17)
Manufacturing (304)
MASH (57)
Medical device (1296)
Medtech (1299)
Mergers & acquisitions (9813)
Metabolic disorders (372)
Multiple sclerosis (38)
NASH (14)
Neurodegenerative disease (56)
Neuropsychiatric disorders (17)
Neuroscience (768)
NextGen: Class of 2025 (1590)
Non-profit (599)
Now hiring (15)
Obesity (195)
Opinion (136)
Ovarian cancer (31)
Pain (90)
Pancreatic cancer (38)
Parkinson's disease (63)
Partnered (9)
Patents (186)
Patient recruitment (85)
Peanut (13)
People (29473)
Pharmaceutical (64)
Pharmacy benefit managers (14)
Phase I (8250)
Phase II (13400)
Phase III (12045)
Pipeline (1057)
Policy (119)
Postmarket research (1403)
Preclinical (3312)
Press Release (25)
Prostate cancer (73)
Psychedelics (14)
Radiopharmaceuticals (126)
Rare diseases (269)
Real estate (2651)
Recruiting (18)
Regulatory (10620)
Reports (15)
Research institute (569)
Resumes & cover letters (55)
Rett syndrome (3)
RNA editing (5)
RSV (16)
Schizophrenia (57)
Series A (63)
Series B (33)
Service/supplier (3)
Sickle cell disease (40)
Special edition (9)
Spinal muscular atrophy (77)
Sponsored (7)
Startups (1640)
State (2)
Stomach cancer (3)
Supply chain (41)
Tariffs (66)
The Weekly (42)
Vaccines (212)
Venture capital (24)
Weight loss (125)
Women's health (12)
Worklife (4)
Date
Today (50)
Last 7 days (257)
Last 30 days (853)
Last 365 days (10890)
2025 (8789)
2024 (12535)
2023 (14270)
2022 (19585)
2021 (20091)
2020 (19046)
2019 (14897)
2018 (11726)
2017 (13902)
2016 (13152)
2015 (15507)
2014 (12435)
2013 (10621)
2012 (11399)
2011 (11929)
2010 (10891)
Location
Africa (317)
Alabama (17)
Alaska (1)
Arizona (68)
Arkansas (3)
Asia (20613)
Australia (2661)
California (2610)
Canada (1283)
China (426)
Colorado (111)
Connecticut (110)
Delaware (100)
Europe (40392)
Florida (507)
Georgia (54)
Hawaii (1)
Idaho (9)
Illinois (285)
India (30)
Indiana (199)
Iowa (1)
Japan (184)
Kansas (71)
Kentucky (17)
Louisiana (2)
Maine (2)
Maryland (373)
Massachusetts (2223)
Michigan (41)
Minnesota (139)
Mississippi (1)
Missouri (29)
Montana (8)
Nebraska (6)
Nevada (16)
New Hampshire (6)
New Jersey (1173)
New Mexico (7)
New York (757)
North Carolina (525)
North Dakota (2)
Northern California (1133)
Ohio (67)
Oklahoma (5)
Oregon (17)
Pennsylvania (624)
Puerto Rico (9)
Rhode Island (15)
South America (505)
South Carolina (7)
Southern California (1122)
Tennessee (46)
Texas (374)
United States (10694)
Utah (52)
Virginia (132)
Washington D.C. (41)
Washington State (180)
West Virginia (1)
Wisconsin (27)
271,268 Results for "mgc pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation
MGC Pharmaceuticals Ltd, Rebrands as Argent BioPharma in Strategic Transformation Marking a significant milestone in its evolutionary journey, MGC Pharma has officially announced its rebranding to Argent BioPharma, pending approval from its shareholders.
February 13, 2024
·
3 min read
MGC Pharma’s CannEpil® Now Accessible to UK Patients on Named Patient Request Basis
MGC Pharmaceuticals Ltd., announces that its proprietary product CannEpil® is now available to patients in the UK by Named Patient Request.
April 11, 2023
·
3 min read
Deals
CAIRE® to Acquire MGC Diagnostics Holdings, Inc.
Portfolio Expands to Include Non-Invasive Cardiorespiratory Diagnostic Systems CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., will acquire St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. MGC designs, develops, manufactures, and markets non-invasive cardiorespiratory diagnostic systems, accessories, and consumables for the detection, classification, and management of cardiorespiratory disease.
November 29, 2022
·
3 min read
Deals
Altus Capital Partners-Backed MGC Diagnostics Corporation Acquires Lemon Medical, GmbH
MGC Diagnostics Corporation (“MGC”), a global medical technology company dedicated to cardiorespiratory health solutions, and a portfolio company of Altus Capital Partners, Inc. (“Altus”), announced today the acquisition of Lemon Medical, GmbH.
November 22, 2021
·
3 min read
Press Releases
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update
Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer’s disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth quarter of calendar year 2026
September 23, 2025
·
12 min read
Press Releases
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
October 3, 2025
·
5 min read
Press Releases
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements
October 14, 2025
·
7 min read
Press Releases
Harrow to Acquire Melt Pharmaceuticals
September 29, 2025
·
8 min read
Press Releases
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin
October 20, 2025
·
3 min read
Drug Development
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
MacroGenics, Inc. (NASDAQ: MGNX) today provided an update on the Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo, previously known as MGC018) in patients with metastatic castration-resistant prostate cancer (mCRPC).
April 3, 2024
·
8 min read
1 of 27,127
Next
